CSIMarket
 
Cryoport inc   (CYRX)
Other Ticker:  
 
 

Cryoport Inc Growth Comparisons

Select each growth Category to receive further Information



CYRX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q4 MRQ) -5.13 % - - -
Q / Q Revenue Growth (Q4 MRQ) 1.96 % - - -
Y / Y Revenue Growth (for 12 months ending Q4 TTM) -1.7 % -15 % - %
Seq. Revenue Growth (for 12 months ending Q4 TTM) -1.31 % -10.71 % - 0.31 %
Revenue 5 Year Average Growth 81.16 % 6.79 % 7.31 % 8.35 %


CYRX's Growth Comparisons in IV. Quarter 2023




Facing -5.13% year on year sales decrease in the forth quarter 2023, to $ 57 millions, Cryoport Inc reported smaller declines than the Major Pharmaceutical Preparations industry with %, and less than % no change in the Healthcare sector.

Comparing the company's Revenue to the third quarter results, sales were higher by 1.96% . On the yearly basis, average annual sales growth for Cryoport Inc is 81.16%, while S & P 500's including only Businesses with the forth quarter 2023 earnings, average annual sales growth is 8.35% over the past five years.


Growth Rates of CYRX's Income in the forth quarter 2023


CYRX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q4 MRQ) - - - -
Seq. Operating Income Change (Q4 MRQ) - - - -
Y / Y Operating Income Growth (Q4 TTM) - -37.6 % -34.72 % -3.54 %
Seq. Operating Income Growth (Q4 TTM) - -20.25 % -12.81 % -0.69 %
Operating Income 5 Year Avg. Change - 4.16 % -0.6 % 7.74 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q4 MRQ) - -48.15 % -20.75 % 4.22 %
Seq. Income from Cont. Ops. Change (Q4 MRQ) - -15.88 % 42.64 % -14.69 %
Y / Y Income from Cont. Ops. Change (Q4 TTM) - -31.28 % -26.66 % -1 %
Seq. Income from Cont. Ops. Change (Q4 TTM) - 5.13 % 11.4 % 1.6 %
Income from Cont. Ops. 5 Year Avg. Change - 0.23 % -4.58 % 7.52 %

CYRX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q4 MRQ) - -47.54 % -20.28 % -0.33 %
Q / Q Net Income Growth (Q4 MRQ) - -72 % -49.18 % -21.73 %
Y / Y Net Income Change (Q4 TTM) - -6.07 % -3.95 % 0.28 %
Seq. Net Income Change (Q4 TTM) - 3.85 % 8.57 % 0.52 %
Net Income 5 Year Avg. Growth - 6.6 % 0.52 % 7.76 %

CYRX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q4 MRQ) - -30.41 % -20.75 % 4.22 %
Seq. EPS from Cont. Ops. Change (Q4 MRQ) - -7.95 % 42.64 % -14.69 %
Y / Y EPS from Cont. Ops. Change (Q4 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q4 TTM) - - - 0 %
EPS from Cont. Ops. 5 Year Avg. Growth - -7.94 % -4.58 % 7.52 %



CYRX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q4 MRQ) - -29.59 % -20.28 % -0.33 %
Q / Q EPS Net Growth (Q4 MRQ) - -69.36 % -49.18 % -21.73 %
Y / Y EPS Net Change (for 12 months ending Q4 TTM) - - - 40318.24 %
Seq. EPS Net Change (for 12 months ending Q4 TTM) - - - 0.03 %
EPS Net 5 Year Avg. Change - 6.6 % 0.52 % 7.76 %



Cryoport Inc reported bottom-line of $ -1.30 in the forth quarter, compare to $ -0.22 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -29.59%, while Healthcare sector decreased by -20.28%, and overall market declined by -0.33%.

Comparing company's EPS to the third quarter results, income per share were higher by 1.96% . On the yearly basis, average annual income per share growth for Cryoport Inc is 81.16%, while S & P 500's including only the businesses with the forth quarter 2023 Results, average annual income per share growth is 7.76% over the past five years.

CYRX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q4 MRQ) -32.07 % -21.14 % -13.64 % -9.06 %
Seq. Free Cash Flow Change (Q4 MRQ) - -24.23 % -10.34 % -3.97 %
Y / Y Free Cash Flow Change (Q4 TTM) - -14.72 % -10.34 % 0.99 %
Seq. Free Cash Flow Change (Q4 TTM) - -3.3 % -2.27 % 3.16 %
Free Cash Flow 5 Year Avg. Change - 13.55 % 9.27 % 9.84 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q4 MRQ) - 100.83 % - -
Seq. Net Cash Flow Change (Q4 MRQ) - 221.99 % - -
Y / Y Net Cash Flow Change (Q4 TTM) - - - -
Seq. Net Cash Flow Change (Q4 TTM) - 82.82 % -45.16 % -
Net Cash Flow 5 Year Avg. Change 41.29 % -0.31 % 4.36 % 26.65 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q4 MRQ) 44.64 % -1.32 % -3.74 % -17.21 %
Seq. Capital Expenditures Change (Q4 MRQ) 6.54 % 9.71 % 11.03 % -0.74 %
Y / Y Capital Expenditures Change (Q4 TTM) 85.56 % 12.72 % 7.98 % 18.72 %
Seq. Capital Expenditures Change (Q4 TTM) 9.19 % 4.9 % 2.69 % 26.63 %
Capital Expenditures 5 Year Avg. Change 132.38 % 10.35 % 7.82 % 7.35 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com